Chapter 8: Degenerative Disorders

Dementia represents a syndrome of significant cognitive deterioration affecting memory, language, and executive function in ways that impair daily independence, and can result from reversible causes such as vitamin B12 deficiency or thyroid dysfunction, or irreversible neurodegenerative processes involving abnormal protein accumulation. Alzheimer's disease, the most prevalent dementia type, features progressive cortical atrophy with characteristic pathological hallmarks including neuritic plaques composed of beta-amyloid and neurofibrillary tangles made of aberrant tau protein that ultimately lead to neuronal death; clinical management relies on cholinesterase inhibitors and memantine to modestly slow cognitive decline while caregivers require substantial education and support. Parkinson's disease involves degeneration of dopaminergic neurons in the substantia nigra, resulting in the cardinal motor features of resting tremor, rigidity, bradykinesia, and postural instability, alongside numerous nonmotor symptoms including depression and autonomic dysfunction; levodopa remains the most effective pharmacological intervention despite long-term complications of motor fluctuations and dyskinesias. Amyotrophic lateral sclerosis is a rapidly progressive and uniformly fatal condition characterized by simultaneous upper and lower motor neuron degeneration that produces weakness beginning in a single limb or the bulbar region and eventually spreading to cause paralysis; while currently incurable with median survival of three to five years, emerging therapies such as riluzole and edaravone offer modest benefits in slowing functional decline. Diagnosis across these conditions requires careful clinical assessment, exclusion of alternative etiologies, and in many cases neuroimaging or biomarker analysis, while management emphasizes symptom control, functional preservation, and comprehensive support for patients and families navigating these devastating illnesses.